Genome Editing Market - Forecast(2024 - 2030)

Report Code: HCR 31056 Report Format: PDF + Excel
Genome Editing Market Size is Estimated to Reach $23 Billion by 2030, Growing at a CAGR of 19.2% during the forecast period 2023-2030.

Genome editing is evolving significantly owing to a rise in population with cancer and other genetic disorders. The process is a precise modification or organism’s DNA which is currently being tested on plants and animals. There has been a continuous advancement in genome editing tools and technologies with CRISPR being the most recent one which has gained tremendous popularity due to its simplicity and precision. This technology is mainly used for targeted editing of specific genes. 

Additionally, growing usage of genome editing for agricultural applications for increasing food production drives the market growth of plant genetic engineering which further enhances the growth of genome editing market during the forecast period.

Market Snapshot:

Genome Editing Market - Report Coverage:

The “Genome Editing Market Report - Forecast (2022-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Genome Editing Market.

                        Attribute

                        Segment



By Product and Service Type

  • Reagents and Consumables

  • Software and Systems

  • Services





By Technology 

  • Restriction Enzymes

  • Zinc-Finger Nucleases (ZFN)

  • Transcription activator-like effector nucleases (TALEN)

  • Clustered regularly interspaced short palindromic repeats (CRISPR)

  • Antisense

  • Others

By Delivery Method

  • Ex- vivo

  • In- vivo

By Mode

  • Contract

  • In- House




By Application

  • Animal Genetic Engineering

  • Plant Genetic Engineering

  • Drug Discovery and Development

  • Diagnostic Applications

  • Cell Line Engineering

  • Others 


By End-User

  • Biotech and Pharma Companies

  • Government and Academic Research Institutes

  • Contract Research Organizations (CRO’s)






By Geography 

  • North America (U.S., Canada and Mexico and Rest of North America)

  • Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe),

  • Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific),

  • South America

  • Rest of the World (Middle East and Africa).







By companies profiled 

  1. Thermo Fisher Scientific,Inc.

  2. Merck KGaA

  3. Integrated DNA Technologies, Inc.

  4. New England Biolabs, Inc.

  5. Sangamo Biosciences, Inc.

  6. Genscript Biotech Corp 

  7.  Agilent Technologies, Inc.

  8. Creative Biogene

  9. IntelliaTherapeutics, Inc.

  10. Lonza Group


COVID-19 / Ukraine Crisis - Impact Analysis:  Key Takeaways:

Due to the global economic crisis caused by the covid, it disrupted many known healthcare sectors across the world. It even has moderate effect on several healthcare services including the genome editing market. But COVID-19 has boosted up the growth of genome editing market as gene editing tool is taken foremost during the pandemic. Furthermore, as COVID-19 is a virus that naturally occurred due to the bacteria, gene editing system plays a key role in the defence against the viral infections.

The Ukraine-Russia conflict has demonstrated the negative impact on genome editing due to increase in the cost of supply chains. Most of the gene editing markets are associating with the United States for gene edited products to differentiate current methodology from older genetically modified Organism Technology that Invoked Consumers, Retailers and Farmers Negatively.

KEY TAKEAWAYS:

North America as the Largest Regional Market for Genome Editing Market
Geographically, North America held the largest share of 41% in the global Genome Editing Market during the year 2022. Major factors driving the growth in North America are- increased usage of gene modified crops, the development in the gene therapy and the rise in the funding. The market in the Canada is expected to experience this growth in future with various initiatives from the government. Although, editing human genes in restricted in Canada and is a punishable offence, but the country’s regulatory system is positioned to accommodate any revolutions or new technologies in plant or animal breeding, including gene editing.

CRISPR Technology is Leading the Market
CRISPR and CRISPER-Cas9 is an immune defense system to edit the DNA and has redefined the approach to gene therapy across the globe owing to their simplicity and being a more efficient alternative to specific gene editing. This technology is leading the overall gene editing market with a market revenue of $2.3 billion in the year 2022 and projected to rise to $9.3 billion growing a double digit CAGR during the forecast period. The first CRISPR gene editing human trial started in the U.S. in 2019 and has resulted in a 100% success in 75 patients treated with efficacy. In 2022, Vertex Pharmaceuticals and CRSIPR Therapeutics presented new data at the European Hematology Association Congress and which revealed that CRISPR Gene editing is safety and effective for up to three years after the treatment. 

Genome Editing Market Share (%) By Region, 2022



Key Market Players: 

The top 10 companies in this Industry are listed below:

  1. Thermo Fisher Scientific,Inc.

  2. Merck KGaA

  3. Integrated DNA Technologies, Inc.

  4. New England Biolabs, Inc.

  5. Sangamo Biosciences, Inc.

  6. Genscript Biotech Corp 

  7. Agilent Technologies, Inc.

  8. Creative Biogene

  9. IntelliaTherapeutics, Inc.

  10. Lonza Group


Scope of Report: 

                      Report Metric

                            Details

Base Year Considered

2022

Forecast Period

2022–2030

CAGR

19.2%

Market Size in 2030

$23 billion

Segments Covered

Product and Service Type, Technologies, Methods, Mode, Application, End User, Geography and Companies Profiled.


Geographies Covered

North America (U.S., Canada and Mexico and Rest of North America), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (), Rest of the World (Middle East and Africa).



Key Market Players


  1. Thermo Fisher Scientific,Inc.

  2. Merck KGaA

  3. Integrated DNA Technologies, Inc.

  4. New England Biolabs, Inc.

  5. Sangamo Biosciences, Inc.

  6. Genscript Biotech Corp 

  7. Agilent Technologies, Inc.

  8. Creative Biogene

  9. IntelliaTherapeutics, Inc.

  10. Lonza Group


For More Lifesciences and Healthcare Market Reports, Please Click Here

1. Genome Editing Market - Overview
        1.1 Definitions and Scope
2. Genome Editing Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Genome Editing Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Genome Editing Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Genome Editing Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Genome Editing Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Genome Editing Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Genome Editing Market - By Product Type(Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
9. Genome Editing Market - By Type(Market Size -$Million / $Billion)
        9.1 MARKET SEGMENTATION
            9.1.1 Technology
                 9.1.1.1 Clustered regularly interspaced short palindromic repeats
                 9.1.1.2 Transcription activator-like effector nuclease
                 9.1.1.3 Zinc Finger Nuclease
                 9.1.1.4 Other Technologies
                 9.1.1.5 Cell Line Editing
                 9.1.1.6 Animal Genome Editing
                 9.1.1.7 Plant Genome Editing
            9.1.2 End user
                 9.1.2.1 Pharmaceutical companies and Biotechnology Companies
                 9.1.2.2 Academics and Government Research Institutes
                 9.1.2.3 Clinical Research Organizations
        9.2 COMPETITIVE LANDSCAPE
10. Genome Editing - By Application Type(Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
11. Genome Editing- By Geography (Market Size -$Million / $Billion)
        11.1 Genome Editing Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Genome Editing- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Genome Editing- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Genome Editing - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Genome Editing - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Genome Editing Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Genome Editing Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Genome Editing Market - Key Company List by Country Premium
15. Genome Editing Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Company 2
        15.3 Company 3 & More
16. Genome Editing Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Genome Editing Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

"Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our 
reports include global-level data, niche markets and competitive landscape.




The Genome Editing Market is projected to grow at 19.2 % CAGR during the forecast period 2022-2030.

Global Genome Editing Market size is estimated to be $5710 million in 2023 and is projected to reach $23164 million by 2030

The leading players in the Genome Editing Market are Thermo Fisher Scientific,Inc., Merck KGaA, Integrated DNA Technologies, Inc., New England Biolabs, Inc., Sangamo Biosciences, Inc., GenScript (China), Agilent Technologies, Inc., Creative Biogene, IntelliaTherapeutics, Inc., Lonza Group and Others.

Development of Vaccines, Drugs and Medical Technologies with the Help of Government Funding, Product Launching According to the Prescribed Patient, Additional Research Studies on CRISPER Technology, Continuous Technological Advancements in Gene-Editing Tools and Introducing New Scientific Proteins are Some of the Major Genome Editing Market Trends in the Industry which will Create Growth Opportunities for the Market During the Forecast Period.

Increasing Expenditures on Development & Research, Growth in the Pharmaceutical Companies, the Demand for Synthetic Genes and Personalised Medicine and Increase in the Infectious Diseases like Cancer are the Driving Factors of the Gene Editing Market.